Literature DB >> 23307349

Ternary polymeric nanoparticles for oral siRNA delivery.

Jing Zhang1, Chunbai He, Cui Tang, Chunhua Yin.   

Abstract

PURPOSE: Poor stability and inefficient absorption in the intestinal tract are major barriers confronting oral delivery of siRNA. We aimed to uncover if ternary polymeric nanoparticles (cationic polymer/siRNA/anionic component) can overcome these obstacles through changing the formulation-related parameters.
METHODS: Ternary polymeric nanoparticles were prepared by ionic gelation of chitosan, N-trimethyl chitosan (TMC), or thiolated trimethyl chitosan (TTMC) with tripolyphosphate (TPP) or hyaluronic acid (HA), and siRNA was simultaneously encapsulated. Structural stabilities and siRNA protection of these nanoparticles were assessed in simulated intestinal milieu. Their transport across ex vivo rat ileum, macrophage uptake, in vitro gene silencing, and in vivo biodistribution after oral administration were investigated.
RESULTS: Ternary polymeric nanoparticles formed by TTMC, siRNA, and TPP (TTMC/siRNA/TPP nanoparticles) showed suitable structural stability and siRNA protection in the intestinal tract, good permeability across ex vivo rat ileum, superior cellular uptake and gene silencing efficiency in Raw 264.7 cells, and high systemic biodistribution after oral administration.
CONCLUSIONS: TTMC/siRNA/TPP nanoparticles demonstrated efficient gene silencing in vitro and systemic biodistribution in vivo, therefore, they were expected to be potential vehicles for oral siRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307349     DOI: 10.1007/s11095-012-0961-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  38 in total

Review 1.  Thiolated chitosans.

Authors:  Andreas Bernkop-Schnürch; Margit Hornof; Davide Guggi
Journal:  Eur J Pharm Biopharm       Date:  2004-01       Impact factor: 5.571

2.  Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.

Authors:  Yueling Zhang; Wei Wei; Piping Lv; Lianyan Wang; Guanghui Ma
Journal:  Eur J Pharm Biopharm       Date:  2010-10-07       Impact factor: 5.571

Review 3.  Is the oral route possible for peptide and protein drug delivery?

Authors:  Mariko Morishita; Nicholas A Peppas
Journal:  Drug Discov Today       Date:  2006-09-07       Impact factor: 7.851

4.  Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.

Authors:  Yongmei Xu; Changyou Zhan; Lihong Fan; Le Wang; Hua Zheng
Journal:  Int J Pharm       Date:  2006-12-20       Impact factor: 5.875

5.  Bioadhesion and oral absorption of enoxaparin nanocomplexes.

Authors:  Wei Sun; Shirui Mao; Yanjun Wang; Varaporn B Junyaprasert; Tingting Zhang; Lidong Na; Juan Wang
Journal:  Int J Pharm       Date:  2009-12-01       Impact factor: 5.875

6.  Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.

Authors:  Dong Wook Lee; Kyoung-Soo Yun; Hong-Seok Ban; Wonchae Choe; Sang Kyung Lee; Kuen Yong Lee
Journal:  J Control Release       Date:  2009-06-28       Impact factor: 9.776

Review 7.  Polymers in small-interfering RNA delivery.

Authors:  Kaushik Singha; Ran Namgung; Won Jong Kim
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

8.  Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.

Authors:  Myriam Aouadi; Gregory J Tesz; Sarah M Nicoloro; Mengxi Wang; My Chouinard; Ernesto Soto; Gary R Ostroff; Michael P Czech
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

9.  Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency.

Authors:  Xin Zhao; Lichen Yin; Jieying Ding; Cui Tang; Shaohua Gu; Chunhua Yin; Yumin Mao
Journal:  J Control Release       Date:  2010-01-20       Impact factor: 9.776

10.  Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.

Authors:  Oliver Germershaus; Shirui Mao; Johannes Sitterberg; Udo Bakowsky; Thomas Kissel
Journal:  J Control Release       Date:  2007-10-23       Impact factor: 9.776

View more
  6 in total

1.  Anionic Polymer and Quantum Dot Excipients to Facilitate siRNA Release and Self-Reporting of Disassembly in Stimuli-Responsive Nanocarrier Formulations.

Authors:  Chad T Greco; Jason C Andrechak; Thomas H Epps; Millicent O Sullivan
Journal:  Biomacromolecules       Date:  2017-05-10       Impact factor: 6.988

Review 2.  Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.

Authors:  Neha Kumari; Kasturi Siddhanta; Sudipta Panja; Vineet Joshi; Chinmay Jogdeo; Ekta Kapoor; Rubayat Khan; Sai Sundeep Kollala; Balawant Kumar; Diptesh Sil; Amar B Singh; Daryl J Murry; David Oupický
Journal:  Pharm Res       Date:  2022-10-21       Impact factor: 4.580

3.  Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.

Authors:  Chunbai He; Lichen Yin; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-05-29       Impact factor: 4.200

Review 4.  Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics.

Authors:  Young Hee Choi; Hyo-Kyung Han
Journal:  J Pharm Investig       Date:  2017-11-28

Review 5.  Nanodrugs: pharmacokinetics and safety.

Authors:  Satomi Onoue; Shizuo Yamada; Hak-Kim Chan
Journal:  Int J Nanomedicine       Date:  2014-02-20

6.  New aspects of gene-silencing for the treatment of cardiovascular diseases.

Authors:  Olivia Koenig; Tobias Walker; Nadja Perle; Almuth Zech; Bernd Neumann; Christian Schlensak; Hans-Peter Wendel; Andrea Nolte
Journal:  Pharmaceuticals (Basel)       Date:  2013-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.